{"id":105365,"date":"2025-10-27T08:11:56","date_gmt":"2025-10-27T13:11:56","guid":{"rendered":"https:\/\/www.erdheim-chester.org\/?p=105365"},"modified":"2025-10-27T08:41:55","modified_gmt":"2025-10-27T13:41:55","slug":"new-hope-in-targeted-therapy-for-histiocytosis","status":"publish","type":"post","link":"https:\/\/www.erdheim-chester.org\/hi\/new-hope-in-targeted-therapy-for-histiocytosis\/","title":{"rendered":"New Hope in Targeted Therapy for Histiocytosis"},"content":{"rendered":"<div>\n<p class=\"x_MsoNormal\"><span data-olk-copy-source=\"MessageBody\">A new study from\u00a0<b>\u092e\u0947\u092e\u094b\u0930\u093f\u092f\u0932 \u0938\u094d\u0932\u094b\u0928 \u0915\u0947\u091f\u0930\u093f\u0902\u0917 \u0915\u0948\u0902\u0938\u0930 \u0938\u0947\u0902\u091f\u0930<\/b>\u00a0highlights the promise of\u00a0<b>ulixertinib<\/b>, a targeted therapy drug that blocks ERK, for treating certain forms of\u00a0<b>histiocytosis,<\/b>\u00a0including <b>Erdheim-Chester Disease (ECD)<\/b>.<\/span><\/p>\n<p class=\"x_MsoNormal\">Led by Dr. Eli Diamond, a member of the ECDGA Medical Advisory Board, this research marks an exciting step forward in the treatment of MAPK-driven histiocytic disorders. For many in our community, like Joey, a member of the ECDGA whose journey continues to inspire us, these scientific breakthroughs represent far more than clinical progress. They offer hope.<\/p>\n<p class=\"x_MsoNormal\">Read the news article from MSKCC:<br \/>\n<a title=\"https:\/\/www.mskcc.org\/news\/targeted-therapy-drug-ulixertinib-for-histiocytosis-blood\" href=\"https:\/\/www.mskcc.org\/news\/targeted-therapy-drug-ulixertinib-for-histiocytosis-blood\" target=\"_blank\" rel=\"noopener\" data-auth=\"NotApplicable\" data-linkindex=\"2\">https:\/\/www.mskcc.org\/news\/targeted-therapy-drug-ulixertinib-for-histiocytosis-blood<\/a><\/p>\n<p class=\"x_MsoNormal\">Access the full technical article in <i>Cancer Cell<\/i>:<br \/>\n<a title=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1535610825004064\" href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1535610825004064\" target=\"_blank\" rel=\"noopener\" data-auth=\"NotApplicable\" data-linkindex=\"3\">https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1535610825004064<\/a><\/p>\n<p class=\"x_MsoNormal\">At ECDGA, we are proud to support and share research that drives us closer to better care, more answers, and, someday, a cure.<\/p>\n<p><em>The Erdheim-Chester Disease Global Alliance (ECDGA) does not provide medical advice, diagnoses, or treatments. All content is for informational purposes only. Please consult with a healthcare provider for medical concerns.<\/em><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>A new study from Memorial Sloan Kettering Cancer Center highlights the promise of ulixertinib, a targeted therapy drug that blocks ERK, for treating certain forms of histiocytosis \u2014 including Erdheim-Chester Disease (ECD).<\/p>","protected":false},"author":14,"featured_media":105366,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","cybocfi_hide_featured_image":"","wds_primary_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[51],"tags":[375,2599,5100,5103,5107,102,5104,5105,5106,3473,5101,4254,5108,5102,4957],"class_list":["post-105365","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-ecdawareness","tag-elidiamond","tag-erdheim-chesterdisease","tag-erkinhibitor","tag-histiocyticdisorders","tag-histiocytosis","tag-mapkpathway","tag-memorialsloankettering","tag-precisionmedicine","tag-rarebloodcancer","tag-rarecancer","tag-rarediseaseresearch","tag-researchbreakthrough","tag-targetedtherapy","tag-ulixertinib"],"_links":{"self":[{"href":"https:\/\/www.erdheim-chester.org\/hi\/wp-json\/wp\/v2\/posts\/105365","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.erdheim-chester.org\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.erdheim-chester.org\/hi\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/hi\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/hi\/wp-json\/wp\/v2\/comments?post=105365"}],"version-history":[{"count":0,"href":"https:\/\/www.erdheim-chester.org\/hi\/wp-json\/wp\/v2\/posts\/105365\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/hi\/wp-json\/wp\/v2\/media\/105366"}],"wp:attachment":[{"href":"https:\/\/www.erdheim-chester.org\/hi\/wp-json\/wp\/v2\/media?parent=105365"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/hi\/wp-json\/wp\/v2\/categories?post=105365"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/hi\/wp-json\/wp\/v2\/tags?post=105365"}],"curies":[{"name":"\u0921\u092c\u094d\u0932\u094d\u092f\u0942\u092a\u0940","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}